Hot Features
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company’s lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac diseas... Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company’s lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac disease, vitiligo, alopecia areata, and type 1 diabetes. Forte Biosciences, Inc. is headquartered in Dallas, Texas. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.15 | 0.879765395894 | 17.05 | 18.09 | 15.51 | 320118 | 16.58920995 | CS |
| 4 | -7.27 | -29.7098487944 | 24.47 | 25.01 | 15.51 | 262430 | 19.01439116 | CS |
| 12 | -7.4 | -30.081300813 | 24.6 | 35.7999 | 15.51 | 308879 | 26.57111958 | CS |
| 26 | -3.23 | -15.810083211 | 20.43 | 35.7999 | 15.51 | 257064 | 27.62634691 | CS |
| 52 | 4.97 | 40.6377759608 | 12.23 | 35.7999 | 9.1 | 178462 | 23.48541797 | CS |
| 156 | 16.19 | 1602.97029703 | 1.01 | 35.7999 | 0.2796 | 132345 | 16.00287948 | CS |
| 260 | -23.63 | -57.8741121724 | 40.83 | 41.81 | 0.2796 | 253997 | 9.31627374 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.